Skip to main content

Hoge Stephen's Form 4 filing

Moderna, Inc.MRNA · filed Nov 18, 2026

Accession no.
0001682852-26-000210
Filed
Nov 18, 2026, 4:36 PM ET
Trade date
Nov 16-17, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $16.9M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hoge StephenCIK 0001760669Officer (President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 16, 2026Common StockMOption exerciseAcquired+76,453$12.21+$933,491.131,713,018Direct
Nov 16, 2026Common StockSSaleDisposed−39,160$219.66F2−$8,601,885.61,673,858Direct
Nov 16, 2026Common StockGGiftDisposed−400,000$0.00F3$01,273,858Direct
Nov 17, 2026Common StockMOption exerciseAcquired+76,452$12.21+$933,478.921,350,310Direct
Nov 17, 2026Common StockSSaleDisposed−33,976$211.45F4−$7,184,225.21,316,334Direct
Nov 17, 2026Common StockSSaleDisposed−5,082$212.57F5−$1,080,280.741,311,252Direct
Nov 17, 2026Common StockSSaleDisposed−157$214.19F6−$33,627.831,311,095Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 16, 2026Common StockMOption exerciseDisposed−76,453$0.00$076,452Direct
Nov 17, 2026Common StockMOption exerciseDisposed−76,452$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $219.54 to $220.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F3

The reported disposition represents a bona fide charitable gift made by the reporting person.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $211.41 to $212.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $212.50 to $213.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $213.92 to $214.50. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)